Understand the source comparison
Selank Amidate vs Lexapro: Research Peptide Comparison
Mechanism of Action GABA-A receptor modulation + enkephalin degradation inhibition Selective serotonin reuptake inhibition (SSRI) via SERT blockade Completely different neurochemical pathways. Not interchangeable mechanisms Onset of Anxiolytic Effect 30–60 min
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Mechanism of Action
- GABA-A receptor modulation + enkephalin degradation inhibition
- Selective serotonin reuptake inhibition (SSRI) via SERT blockade
- Completely different neurochemical pathways. Not interchangeable mechanisms
- Onset of Anxiolytic Effect
- 30–60 minutes post-intranasal administration
- 2–4 weeks of daily dosing required for therapeutic effect
- Selank provides immediate response; Lexapro requires receptor adaptation period
- Administration Route
- Intranasal spray, 300–600mcg per dose, 2–3× daily
- Oral tablet, 10–20mg once daily
- Selank requires multiple daily doses; Lexapro is once-daily convenience
- Sexual Dysfunction Risk
- No documented sexual side effects in published research
- 40–65% incidence (delayed orgasm, reduced libido, anorgasmia)
- Selank avoids serotonergic sexual dysfunction entirely
- Discontinuation Syndrome
- No withdrawal symptoms documented. No receptor adaptation required
- SSRI discontinuation syndrome common (brain zaps, dizziness, rebound anxiety)
- Selank stops cleanly; Lexapro requires tapering after prolonged use
- Storage Requirements
- −20°C before reconstitution; 2–8°C after mixing; 28-day use window
- Room temperature stable for 2+ years
- Selank demands cold chain; Lexapro has no special storage needs